(Q80094708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

main subject

metastatic breast cancer

1 reference

Allan Lipton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Suhail M Ali

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kim Leitzel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Laurence Demers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Dean B Evans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Peter Hamer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sheryl Brown-Shimer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Karen Pierce

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Walter Carney

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1933-1939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

Changing views of the role of matrix metalloproteinases in metastasis

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Molecular characterization and expression of the gene encoding human erythroid-potentiating activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Matrix metalloproteinases in carcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Tissue inhibitor of metalloproteinases-1 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22637

7 January 2021

Identifiers

DOI

10.1002/CNCR.22637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17407159%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference